載入...
A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance
BACKGROUND: Pain accompanies rheumatoid arthritis and other chronic inflammatory conditions and is difficult to manage. Although opioids provide potent analgesia, chronic opioid use can cause tolerance and addiction. Recent studies have demonstrated functional interactions between chemokine and opio...
Na minha lista:
| 發表在: | Arthritis Res Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6062996/ https://ncbi.nlm.nih.gov/pubmed/30053832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1661-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|